粤万年青 reported revenue of ¥0.14B for the period ended 2026-06-30, -6.5% year on year. Net income was ¥0.00B, a 1.4% net margin on a 57.2% gross margin. The largest revenue line is 药品 at 77% of the total. Free cash flow for the period was ¥-0.00B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.14B | -6.5% |
| Gross profit | ¥0.08B | — |
| Operating income | ¥0.00B | — |
| Net income | ¥0.00B | — |
| Gross margin | 57.2% | Net margin 1.4% |
| Revenue Q/Q | +18.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 药品 | ¥0.11B | 77.0% |
| 医疗服务及健康管理 | ¥0.02B | 15.9% |
| 健康消费品 | ¥0.01B | 6.6% |
| 其他(补充) | ¥0.00B | 0.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.06B | 42.8% |
| R&D | ¥0.00B | 2.8% |
| SG&A | ¥0.08B | 52.2% |
| Tax & other | ¥0.00B | 0.1% |
| Item | Amount |
|---|---|
| Total assets | ¥0.91B |
| Total liabilities | ¥0.15B |
| Shareholders' equity | ¥0.75B |
| Equity / assets | 83.1% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.00B |
| Cash conversion (OCF / net income) | 24% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
信邦智能 ・ 雅艺科技 ・ 联检科技 ・ 益客食品 ・ 佳缘科技 ・ 恒光股份 ・ 正强股份 ・ 新特电气 ・ 紫建电子 ・ 采纳股份 ・ 奕东电子 ・ 腾亚精工
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies